Global Medical Tech Companies Hamilton Bonaduz and Sonova Select ANAQUA for IP Management

Continental Europe News

24
Sep
2019

Editor

Anaqua, the leading provider of innovation and intellectual property management solutions, today announced that Switzerland-based medical technology companies Hamilton Bonaduz and Sonova have both selected the ANAQUA platform to manage their global patent and trademark portfolios. 

The agreements further expand Anaqua’s presence in the important DACH (Germany, Austria, and Switzerland) region.

“We are excited to welcome two more global innovators, Hamilton Bonaduz and Sonova, to Anaqua’s growing client community,” said Bob Romeo, CEO of Anaqua. “Their joining reflects Anaqua’s continued growth in the DACH region as well as our collaboration with clients around the world to transform IP into business success.”  

Hamilton Bonaduz specializes in the development, manufacturing, and customization of precision measurement devices, automated liquid handling workstations, and sample management systems. With ANAQUA, Hamilton Bonaduz’s IP department now has access to a unified, end-to-end innovation management system – from idea capture through prosecution to portfolio management and monetization. The company will also leverage Anaqua’s Financial Management solution to support the IP team’s full spend lifecycle.  

Also joining the Anaqua client community is Sonova, a leading provider of innovative hearing care solutions. The company offers its customers one of the most comprehensive product portfolios in the industry – from hearing instruments to cochlear implants to wireless communication solutions. Sonova will use ANAQUA software to ensure the efficient management and prosecution of the company’s valuable intellectual property assets, including the acceleration of its patent and trademark management processes. Sonova can also access Anaqua’s patent search and analytics platform AcclaimIPTM, a database of over 100 million global patent records users can leverage to track competitors, make more informed filing, licensing and renewal decisions, and monetize their patent portfolio.